Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia (vol 24, pg 103, 2020)

被引：0

|

作者：

Ganz, M. L.

Chavan, A.

Dhanda, R.

Serbin, M.

Yonan, C.

机构：

来源：

JOURNAL OF MEDICAL ECONOMICS | 2021年 / 24卷 / 01期

关键词：

D O I：

10.1080/13696998.2021.1977458

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：1108 / 1108

页数：1

相关论文

共 50 条

[1] Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia
Ganz, Michael L.
Chavan, Ameya
Dhanda, Rahul
Serbin, Michael
Yonan, Charles
[J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 103 - 113
[2] LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA
Harrigan, K.
Walton, S. M.
Huang, S. P.
Kumar, V. M.
Chapman, R. H.
Atlas, S. J.
Agboola, F. O.
Ollendorf, D. A.
Touchette, D. R.
[J]. VALUE IN HEALTH, 2018, 21 : S184 - S184
[3] A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
Patel, Rikinkumar S.
Mansuri, Zeeshan
Motiwala, Fatima
Saeed, Hina
Jannareddy, Namrata
Patel, Hiren
Zafar, Muhammad Khalid
[J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2019, 9
[4] Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113
Xue, Weiguang
Ribalov, Rinat
Zhou, Zheng-Yi
Ayyagari, Rajeev
Leo, Sam
[J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 835 - 836
[5] COST-EFFECTIVENESS ANALYSIS OF VALBENAZINE COMPARED WITH DEUTETRABENAZINE FOR THE MANAGEMENT OF HUNTINGTON CHOREA
Kim, H.
[J]. VALUE IN HEALTH, 2023, 26 (06) : S65 - S65
[6] Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia
Aggarwal, Saurabh
Serbin, Michael
Yonan, Chuck
[J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1077 - 1088
[7] CLINICAL EFFICACY OF VALBENAZINE AND DEUTETRABENAZINE FOR THE TREATMENT OF TARDIVE DYSKINESIA: INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS
Aggarwal, S.
Serbin, M.
Yonan, C.
[J]. VALUE IN HEALTH, 2019, 22 : S272 - S272
[8] EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE
Ganz, M.
Stern, S.
Chavan, A.
Serbin, M.
Yonan, C.
[J]. VALUE IN HEALTH, 2019, 22 : S275 - S275
[9] In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113
Serbin, Michael
Yonan, Charles
Ganz, Michael L.
[J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 891 - 892
[10] Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK (vol 24, pg 1841, 2019)
Guest, J. F.
Clegg, J. P.
Helter, Timea Mariann
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (03) : 525 - 525

← 1 2 3 4 5 →